Docosahexaenoic acid modulates a HER2‐associated lipogenic phenotype, induces apoptosis, and increases trastuzumab action in HER2‐overexpressing breast …

GR Ravacci, MM Brentani, TC Tortelli… - BioMed research …, 2015 - Wiley Online Library
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

Docosahexaenoic acid modulates a HER2-associated lipogenic phenotype, induces apoptosis, and increases trastuzumab action in HER2-overexpressing breast …

GR Ravacci, MM Brentani, TC Tortelli… - BioMed Research …, 2015 - go.gale.com
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast …

GR Ravacci, MM Brentani, TC Tortelli… - BioMed Research …, 2015 - search.proquest.com
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast …

GR Ravacci, MM Brentani… - BioMed research …, 2015 - pubmed.ncbi.nlm.nih.gov
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

[PDF][PDF] Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing …

GR Ravacci, MM Brentani, TC Tortelli, RSMM Torrinhas… - 2015 - pdfs.semanticscholar.org
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

Docosahexaenoic acid modulates a HER2-associated lipogenic phenotype, induces apoptosis, and increases trastuzumab action in HER2-overexpressing breast …

GR Ravacci, MM Brentani, TC Tortelli, R Torrinhas… - 2015 - cabidigitallibrary.org
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

[PDF][PDF] Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing …

GR Ravacci, MM Brentani, TC Tortelli, RSMM Torrinhas… - 2015 - researchgate.net
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

[HTML][HTML] Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing …

GR Ravacci, MM Brentani, TC Tortelli… - BioMed Research …, 2015 - ncbi.nlm.nih.gov
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …

[引用][C] Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing …

GR Ravacci, MM Brentani, TC Tortelli… - Biomed Research …, 2015 - repositorio.usp.br
ReP USP - Detalhe do registro: Docosahexaenoic Acid Modulates a HER2-Associated
Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing …

Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast …

GR Ravacci, MM Brentani, TC Tortelli… - BioMed Research …, 2015 - hero.epa.gov
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic
stimuli that may promote malignancy. To investigate whether the oncogenic nature of …